Advancing the Dose
An educational podcast for healthcare professionals
Featured episode
The myth of CGM MARD
CGM is widely used by people living with type 1 diabetes and is an integral component of automated insulin delivery (AID) systems, like the MiniMed™ 780G system. MARD has been historically used to evaluate the accuracy of CGM systems. What are the limitations of this metric and how useful is it when evaluating AID system accuracy?
More episodes
EPISODE 2
All about the MiniMed™ 780G algorithm
with Bob Vigersky, MD, Chief Medical Officer | Medtronic Diabetes and Lou Lintereur, Sr. Distinguished Engineer | Medtronic Diabetes
episode 1
Consequences of Hyperglycemia and Why Tighter Management is Crucial
An estimated 2 million Americans are living with type 1 diabetes.* How are we doing as a nation in meeting glycemic targets? In this episode, we discuss the current state of diabetes in the U.S., the risks of hyperglycemia, and why striving for tighter management is crucial.
*
Statistics gathered from CDC National Diabetes Statistics Report
Coming soon
- The myth of CGM MARD
- Switching patients from MDI to the MiniMed™ 780G system
- Back to school with automation
- Is carb counting becoming obsolete?
- Starting AID in high-risk populations
- Optimizing AID through settings
- And more!
